US Patent 11246850 Methods of treating multiple sclerosis
Patent 11246850 was granted and assigned to Biogen on February, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11246850 Methods of treating multiple sclerosis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
